IP Library Granted Patent US 7,902,148
Granted Patent B2
US 7,902,148 · App. 12/243,076 · Granted Mar 8, 2011

Use of an echinocandin antifungal agent in combination with a glycopeptide antibacterial agent

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,902,148
App. No.
12/243,076
Granted
Mar 8, 2011
Kind
B2
Abstract

This invention is directed to methods of administering an echinocandin antifungal agent in combination with a glycopeptide antibacterial agent having a substituent comprising at least about 8 carbon atoms. The invention is also directed to methods of using an echinocandin antifungal agent in combination with a specified glycopeptide antibacterial agent to treat fungal infections; and to compositions, kits and systems comprising an echinocandin antifungal agent and a specified glycopeptide antibacterial agent.

Claims (6)

1. A kit comprising:

(a) caspofungin or a pharmaceutically acceptable salt thereof; and

(b) telavancin or a pharmaceutically acceptable salt thereof.

2. The kit according to claim 1 , wherein the kit further comprises instructions for administering (a) caspofungin or a pharmaceutically acceptable salt thereof and (b) telavancin or a pharmaceutically acceptable salt thereof to a subject.

3. The kit according to claim 1 , wherein (a) caspofungin or a pharmaceutically acceptable salt thereof and (b) telavancin or a pharmaceutically acceptable salt thereof are present as separate pharmaceutical compositions.

4. The kit according to claim 1 , wherein (a) caspofungin or a pharmaceutically acceptable salt thereof and (b) telavancin or a pharmaceutically acceptable salt thereof are present in a single pharmaceutical composition.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 14, 2018
From: THERAVANCE BIOPHARMA ANTIBIOTICS IP, LLC
To: CUMBERLAND PHARMACEUTICALS INC.
Reel/Frame 047909/0853 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 12, 2014
From: THERAVANCE, INC.
To: THERAVANCE BIOPHARMA ANTIBIOTICS IP, LLC
Reel/Frame 033180/0672 →